Management of Patient-Reported Outcome (PRO) Alerts in Clinical Trials: A Cross Sectional Survey.

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Kyte, Derek ^a   Ives, Jonathan ^a   Draper, Heather ^a   Calvert, Melanie ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; CLINICAL RESEARCH; CLINICAL TRIAL; DOCTOR PATIENT RELATION; DOCUMENTATION; EXPOSURE; HUMAN; MANAGER; NURSE; PATIENT SAFETY; PERSONNEL; QUANTITATIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STAFF; THEMATIC ANALYSIS; VOLUNTEER; ADULT; AGED; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DISEASE MANAGEMENT; FEMALE; HEALTH CARE SURVEY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT CARE; SELF REPORT; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PATIENT-CENTERED CARE; RESEARCH PERSONNEL; SELF REPORT; YOUNG ADULT;

EID: 84958225940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144658     Document Type: Article

References (24)

1. Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, et al. Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-making. European journal of cancer (Oxford, England: 1990). 2014. Epub 2014/05/16. doi: 10.1016/j.ejca.2014.04.005 PMID: 24825114.
2. Brundage M, Leis A, Bezjak A, Feldman-Stewart D, Degner L, Velji K, et al. Cancer patients' preferences for communicating clinical trial quality of life information: A qualitative study. Quality of Life Research. 2003; 12:395-404. PMID: 12797712
3. Joyce Davidson B, Goldenberg L, Gleave ME, Degner L. Provision of Individualized Information to Men and Their Partners to Facilitate Treatment Decision Making in Prostate Cancer. Oncology Nursing Forum. 2003; 30(1):107-14. PMID: 12515988
4. Snyder CF, Aaronson N, Chouchair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Quality of Life Research. 2011; 21(8):1305-14. doi: 10.1007/s11136-011-0054-x PMID: 22048932
5. Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, et al. The Use of Patientreported Outcomes (PRO) Within Comparative Effectiveness Research: Implications for Clinical Practice and Health Care Policy. Medical Care. 2012; 50(12):1060-70. doi: 10.1097/MLR. 0b013e318268aaff PMID: 22922434
6. Basch EM, Abernethy A, Mullins CD, Tiglao MR, Tunis SR. Development of a guidance for including patient-reported outcomes (PROS) in post-Approval clinical trials of oncology drugs for comparative effectiveness research (CER). Value in Health. 2011; 14 (3):A10. PMID: 70490494.
7. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013; 346:f167. doi: 10.1136/bmj.f167 PMID: 23358487
8. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology. 2008; 26(8):1355-63. doi: 10.1200/JCO. 2007.13.3439 PMID: 18227528
9. Kyte DG, Draper H, Calvert M. Patient-Reported Outcome Alerts: Ethical and Logistical Considerations in Clinical Trials. JAMA. 2013; 310(12):1229-30. doi: 10.1001/jama.2013.277222 PMID: 24065005
10. Kyte D, Ives J, Draper H, Keeley T, Calvert M. Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLoS One. 2013; 8(10): e76625. Epub 2013/10/15. doi: 10.1371/journal.pone.0076625 PMID: 24124580; PubMed Central PMCID: PMCPmc3790726.
11. FDA. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available: http://wwwfdagov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282pdf. 2009.
12. Kyte D, Draper H, Calvert M. Patient-reported outcome alerts: ethical and logistical considerations in clinical trials. JAMA. 2013; 310(12):1229-30. Epub 2013/09/26. doi: 10.1001/jama.2013.277222 PMID: 24065005.
13. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qualitative health research. 2005; 15(9):1277-88. Epub 2005/10/06. doi: 10.1177/1049732305276687 PMID: 16204405.
14. Calvert M, Kyte D, von Hildebrand M, King M, Moher D. Putting patients at the heart of health-care research. Lancet. 2015; 385(9973):1073-4. Epub 2015/03/24. doi: 10.1016/s0140-6736(15)60599-2 PMID: 25797557.
15. EU. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. The European Parliament and the Council of the European Union. 2001.
16. EU. Directive 2005/28/EC of 8 April 2005: laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Official Journal of the European Union; 2005.
17. FDA. Code of Federal Regulations Title 21 Food And Drugs Chapter I Food And Drug Administration Department Of Health And Human Services Part 50 Protection Of Human Subjects. 2014. Available: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50&showFR=1. Accessed March 2015.
18. HSS. Code of Federal Regulations Title 45 Public Welfare Department Of Health And Human Services Part 46 Protection Of Human Subjects. 2009; Available: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Accessed March 2015.
19. ICH. ICH Harmonised Tripartate Guideline for Good Clinical Practice ER(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1996.
20. WMA. WMA Declaration of Helsinki-Ethical Principals for Medical Research Involving Human Subjects. World Medical Association. 2013.
21. Raboud JM, Singer J, Thorne A, Schechter MT, Shafran SD. Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death. Qual Life Res. 1998; 7(6):487-94. Epub 1998/09/16. PMID: 9737138.
22. Sackett DL. Clinician-trialist rounds: 5. Cointervention bias ? how to diagnose it in their trial and prevent it in yours. Clinical Trials. 2011; 8:440-2. doi: 10.1177/1740774511410995 PMID: 21835863
23. Kyte D, Duffy H, Fletcher B, Gheorghe A, Mercieca-Bebber R, King M, et al. Systematic Evaluation of the Patient-Reported Outcome (PRO) Content of Clinical Trial Protocols. PLoS ONE. 2014; 9(10): e110229. doi: 10.1371/journal.pone.0110229 PMID: 25333349
24. Kyte D, Draper H, Ives J, Liles C, Gheorghe A, Calvert M. Patient Reported Outcomes (PROs) in Clinical Trials: Is 'In-Trial' Guidance Lacking? A Systematic Review. PLoS ONE. 2013; 8(4): e60684. doi: 10.1371/journal.pone.0060684 PMID: 23560103